Follow the Pundits
Tag: Baker Bros
ACADIA Pharmaceuticals: Biotech Powerhouse Baker Bros Still Believes. Should You Buy In?
Biotech heavyweight Baker Bros still owns over 25% of ACADIA Pharmaceuticals (ACAD), and the stock is heating up. With expanding revenue, a rich CNS pipeline, and smart money backing it, is this the comeback story investors have been waiting for?
The Best Hedge Funds for Exceptional Investment Returns
This article lists some of the most successful hedge funds based on the quality of their management, track record, key strategic focus, risk management, fee structure, and other criteria. Hedge funds follow various strategies to offer investors a compelling, but risky investment alternative. Investing with one requires a high minimum investment and specific wealth profile (high net worth, high-income generation threshold) from accredited investors. Hedge funds charge (approx.) a 2% management and 20% performance fee. The idea or hope is that they are worth it.